1. Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 Suppl 2:S82-89
2. World Health Organization (2015) Global action plan on antimicrobial resistance. WHO. http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf. Accessed 15 Jan 2021
3. Global antimicrobial resistance surveillance system (GLASS) report: early implementation (2020). Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. Available from: https://www.who.int/glass/resources/publications/early-implementation-report-2020/en/. Accessed 15 Jan 2021
4. Boeras DI, Peeling RW, Onyebujoh P, Yahaya AA, Gumede-Moeletsi HN, Ndihokubwayo JB (2016) The WHO AFRO external quality assessment programme (EQAP): linking laboratory networks through EQA programmes. Afr J Lab Med 5(2):560
5. Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C (2016) The economic burden of childhood pneumococcal diseases in The Gambia. Cost Eff Resour Alloc 14:4